18 Papers
Mina Wang is an academic researcher from Beijing University of Chinese Medicine. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 5, co-authored 9 publications. Previous affiliations of Mina Wang include Capital Medical University & Nanyang Technological University.
Chat about Author
Papers
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.
TL;DR: This review consolidates and discusses the latest research in pathogenesis, diagnosis, and treatments of diabetes and sarcopenic obesity.
Diabetes and cancer: Epidemiological and biological links
TL;DR: This minireview consolidates and discusses the epidemiological and biological links between diabetes and various types of cancer, and indicates that diabetes may work as a protective factor for prostate cancer.
115
PPAR-α Modulators as Current and Potential Cancer Treatments.
TL;DR: In this article, a comprehensive review of PPAR-γ applicability in the field of cancer treatment is presented, including the current and potential applications, and challenges in applying PPARγ modulators to cancer treatment, in both laboratory and clinical settings.
Mechanism of Traditional Chinese Medicine in Treating Knee Osteoarthritis
Mina Wang,Mina Wang,Lu Liu,Lu Liu,Claire Shuiqing Zhang,Zehuan Liao,Zehuan Liao,Xiang-Hong Jing,Marc Fishers,Luopeng Zhao,Xiaobai Xu,Bin Li +11 more
TL;DR: It is highlighted that four therapies have different mechanisms but all of them can manage KOA through inhibiting inflammation, which indicates that alternative therapies should be considered as a viable complementary treatment for pain management in clinical practice.
mRNA vaccine in cancer therapy: Current advance and future outlook
Youhuai Li,Mina Wang,Xueqiang Peng,Yingying Yang,Qishuang Chen,Jiaxing Liu,Qing Shen,Ji-yang Tan,Chuyuan Lou,Zehuan Liao,Xue-xiao Li +10 more
TL;DR: This review elaborated on the development of cancer vaccines and mRNA cancer vaccines, as well as the potential biological mechanisms of mRNA cancer vaccine and the latest progress in various tumour treatments, and discussed the challenges and future directions for the field.
43